Target intelligence / Profile preview

DNA topoisomerase II (Top2)

Target
Top2
Molecular classification
Enzyme, DNA-modifying enzyme
01

Overview

DNA topoisomerase II is an essential ATP-dependent enzyme that manages the topology of double-stranded DNA by introducing transient double-strand breaks. This allows it to resolve supercoils, untangle intertwined chromosomes, and facilitate proper chromosome segregation during cell division. The human genome encodes two isoforms—TOP2A and TOP2B—with distinct but overlapping roles. Many anticancer drugs exploit this target by either stabilizing the normally transient cleavage complex formed between the enzyme and cleaved DNA (“topoisomerase poisons,” e.g., etoposide, doxorubicin), or by intercalating into the DNA itself to disrupt enzymatic activity. These mechanisms can lead to cytotoxic double-strand breaks if not properly repaired. Bacterial type II topoisomerases are also important antibiotic targets.

Other names
Type II topoisomeraseTop2Topo IIDNA gyrase (bacterial)Topoisomerase IV (bacterial)TOP2A/TOP2B (human isoforms)
02

Mechanism of action

Inhibition of enzyme activity by stabilizing the covalent cleavage complex between topoisomerase II and DNA (“poisoning”); Intercalation into DNA to disrupt enzyme function.

03

Biological functions

Regulation of DNA topologyResolution of DNA supercoiling and tanglesChromosome segregation during mitosis and meiosisFacilitation of DNA replication and transcription
04

Disease associations

CancerInfection (as a bacterial target)Other diseases involving genomic instability
05

Safety considerations

Myelosuppression/neutropenia from cytotoxicity in dividing cellsSecondary malignancies due to chromosomal translocations or genome instability induced by double-strand breaksCardiotoxicity with some intercalating agents like doxorubicin
06

Interacting drugs

Etoposide

5 more in the full profile.

07

Biomarkers

Overexpression or mutation status in cancer cells may be used as a biomarker for sensitivity to certain chemotherapies targeting this enzyme.

Beyond the preview

Go deeper on DNA topoisomerase II (Top2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA topoisomerase II (Top2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call